Rosuvastatin, which is in the later stages of the US Food and Drug Administration (FDA) approval process, has been shown to produce significantly greater reductions in LDL-C levels compared with atorvastatin, simvastatin, and pravastatin, and allows more patients to meet lipid goals. Ezetimibe, ...
BackgroundCongestive heart failure is a major cause of mortality and morbidity in the elderly but the disease impact on the oldest and sickest population
TO-2 strain cardiomyopathy is progressive, beginning with myolysis, then developing fibrosis followed by hypertrophy and dilation, and culminating in congestive heart failure (Cruz et al., 2007; Escobales and Crespo, 2006). These stages represent the majority of phases seen in humans with ...
Heart rate variability at different stages of congestive heart failureS. ScalviniM. VolterraniE. ZanelliC. ScottiM. PaganiA. Giordano
Thus, in patients with COCM, these changes probably signal late stages of myocardial hypertrophy related to exhaustion of cardiac reserves.H.-J.KnieriemH.KuhnG.BreithardtH.-J.KnieriemH.KuhnG.BreithardtH.KuhnH.-J.KnieriemG.BreithardtBreithardt G, Kuhn H, Knieriem H-J (1977) Prognostic ...
The occurrence of HCC in such a population of patients clearly affects outcomes, as the diagnosis is made at advanced stages. Interestingly, chronic liver injury can be reversible after an improvement in heart function. However, in cases of terminal heart failure, uncontrolled by medical resources ...
Cardiac mechanics during early and confirmed stages of congestive heart failure (CHF) with anasarca in rabbit: A-I. K. El Amrani, B. Riou, M. Clergue, Y. Lecarpentier. INSERM U275, ENSTA. LOA. 91120 Palaiseau. Francedoi:10.1016/0022-2828(90)92007-2None...
1. 1. Daily determinations of weight and venous pressure were made during thirty-four significant changes in the stage of chronic congestive heart failure in twenty-three patients. This included twenty-six instances of recovery and eight of decompensation. 2. 2. In general, the venous pressure ...
Over 26 million individuals globally are affected by heart disease, and its prevalence is rising by 2% yearly. With advances in healthcare technologies, if we predict CHF in the early stages, one of the leading global mortality factors can be reduced. Therefore, the main objective of this ...
biosensors Article Use of Wavelet Transform to Detect Compensated and Decompensated Stages in the Congestive Heart Failure Patient Pratibha Sharma 1,*, Kimberly Newman 1, Carlin S. Long 2, A. J. Gasiewski 1 and Frank Barnes 1 1 ECEE, University of Colorado, Boulder, CO 80309, USA; ...